Molecular pathology of prostate cancer (original) (raw)

Profile image of Angelo MarzoAngelo Marzo

2005, Journal of Clinical Pathology

visibility

description

12 pages

link

1 file

Focus on prostate cancer

Angelo Marzo

Cancer Cell, 2002

View PDFchevron_right

Prostate Cancer, Version 2.2014

Mack Roach

Journal of the National Comprehensive Cancer Network, 2014

View PDFchevron_right

Molecular alterations associated with prostate cancer

adalberto sanchez gomez

Central European Journal of Urology, 2018

View PDFchevron_right

Molecular genetics of prostate cancer

adnan albadran

Annals of Medicine, 2001

View PDFchevron_right

Prostate cancer; the interface between pathology and basic scientific research

Andrew Stubbs

Seminars in Cancer Biology, 1997

View PDFchevron_right

Wagging the long tail of drivers of prostate cancer

Jeffrey Townsend

PLOS Genetics, 2019

View PDFchevron_right

Update on Screening in Prostate Cancer Based on Recent Clinical Trials

Vincenzo Gentile

Reviews on Recent Clinical Trials, 2011

View PDFchevron_right

Five Genetic Variants Associated with Prostate Cancer

Wayne Hall

New England Journal of Medicine, 2008

View PDFchevron_right

Increased Cumulative Incidence of Prostate Malignancies in Colorectal Cancer Patients

Nuri Ozden

International Journal of Gastrointestinal Cancer, 2004

View PDFchevron_right

Editorial: Challenges in the prevention of prostate cancer

Andrea Venerando

Frontiers in Oncology, 2023

View PDFchevron_right

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

Epidemiologic determinants of clinically relevant prostate cancer

Thomas Wheeler

International Journal of Cancer, 2000

View PDFchevron_right

Normal Development and Carcinogenesis of the Prostate

Gerald Cunha

Annals of the New York Academy of Sciences, 1996

View PDFchevron_right

Breast and prostate cancer: more similar than different

Stephen Birrell

Nature Reviews Cancer, 2010

View PDFchevron_right

Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

Scott Lucia

The New England Journal of Medicine, 2004

View PDFchevron_right

Prostate Cancer Risk with Positive Family History, Normal Prostate Examination Findings, and PSA Less Than 4.0 ng/mL

Javier Hernandez

Urology, 2007

View PDFchevron_right

Study of serum prostate specific antigen levels in patients with prostate lesions

DrashtI Shukla

International Journal of Clinical and Diagnostic Pathology, 2021

View PDFchevron_right

Editorial: Molecular drivers of prostate cancer pathogenesis and therapy resistance

Shagun Misra

Frontiers in Cell and Developmental Biology

View PDFchevron_right

Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic, and Therapeutic Targets

Angelo Marzo

Advances in Anatomic Pathology, 2008

View PDFchevron_right

Carcinoma of the prostate: Clinical and pathological staging and prognosis

Jack Elder

The Prostate, 1983

View PDFchevron_right

1664: Pathological Assessment of High Grade Tumors in the Prostate Cancer Prevention Trial (PCPT)

Scott Lucia

The Journal of Urology, 2005

View PDFchevron_right

Prostate cancer immunology - an update for Urologists

Damien Bolton

BJU International, 2011

View PDFchevron_right

An Analysis of Patients with Clinically Localized High-Risk Prostate Carcinoma

Mack Roach

The Prostate Journal, 2000

View PDFchevron_right

Inflammation in prostate carcinogenesis

Angelo Marzo

Nature Reviews Cancer, 2007

View PDFchevron_right

Prostate cancer survivorship

Raj Persad

Trends in Urology & Men's Health, 2014

View PDFchevron_right

Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

Scott Lucia

JNCI: Journal of the National Cancer Institute, 2006

View PDFchevron_right

The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention

Angelo Marzo

Urology, 2001

View PDFchevron_right

Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen

Bernard Candas

Urology, 1996

View PDFchevron_right

Prostate cancer presenting as cervical lymphadenopathy

Sandeep Nath

American Journal of Case Reports, 2012

View PDFchevron_right

Vancouver General Hospital, The Prostate Cancer Center

Mauricio Neira

2007

View PDFchevron_right

Prostate cancer markers: An update (Review)

Sunjit Parmar

Biomedical Reports, 2016

View PDFchevron_right

Survival tactics: prostate cancer

Daniel Kelly

1998

View PDFchevron_right

Screening for Prostate Cancer: Opportunities and Challenges

Javier Hernandez

Surgical Oncology Clinics of North America, 2005

View PDFchevron_right

An Overview on Prostate Pathophysiology: New Insights into Prostate Cancer Clinical Diagnosis

Taize Augusto

Pathophysiology - Altered Physiological States, 2018

View PDFchevron_right

New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia

Angelo Marzo

Urology, 1999

View PDFchevron_right

Molecular mechanisms of metastasis in prostate cancer

Noel Clarke

CRC Press eBooks, 2005

View PDFchevron_right

BiologyInflammationProstate CancerMedicineClinical PathologyMolecular PathologyClinical SciencesOncogenesProstatic neoplasmsChromosome aberrations